Search

Your search keyword '"Oral Submucous Fibrosis pathology"' showing total 460 results

Search Constraints

Start Over You searched for: Descriptor "Oral Submucous Fibrosis pathology" Remove constraint Descriptor: "Oral Submucous Fibrosis pathology"
460 results on '"Oral Submucous Fibrosis pathology"'

Search Results

1. Diagnostic potential of salivary IL-1β, IL-8, SAT, S100P, and OAZ1 in oral squamous cell carcinoma, oral submucous fibrosis, and oral lichen planus based on findings from a Sri Lankan cohort.

2. The role of M1 (CD11c) and M2 (CD163) interplay in the pathogenesis of oral submucous fibrosis and its malignant transformation: An immunohistochemical analysis.

3. Role of mast cells in the pathogenesis of oral submucous fibrosis: a systematic review and meta-analysis.

4. MIAT promotes myofibroblastic activities and transformation in oral submucous fibrosis through sponging the miR-342-3p/SOX6 axis.

5. SFRP1 reduces neutrophil infiltration and inhibits the Wnt/β-catenin pathway to alleviate oral submucous fibrosis.

7. Novel role of CD34+ stromal cells/telocytes in oral submucous fibrosis development and its malignant transformation.

8. High-resolution AI image dataset for diagnosing oral submucous fibrosis and squamous cell carcinoma.

9. Carvacrol inhibits the progression of oral submucous fibrosis via downregulation of PVT1/miR-20a-5p-mediated pyroptosis.

10. Comparative analysis of two arecoline-induced oral submucous fibrosis models.

11. Expression profile of diagnostic genes in oral submucous fibrosis.

12. Role of Stem Cells in the Pathogenesis and Malignant Transformation of Oral Submucous Fibrosis.

13. circMTO1/miR-30c-5p/SOCS3 axis alleviates oral submucous fibrosis through inhibiting fibroblast-myofibroblast transition.

14. Alteration of salivary LPO, MDA, LDH, glutathione, GPx, SOD and vitamins in oral submucous fibrosis: A three-level meta-analysis study.

15. Evaluation of salivary endothelin-1 as a biomarker for oral cancer and precancer.

16. Exosomal miR-17-5p derived from epithelial cells is involved in aberrant epithelium-fibroblast crosstalk and induces the development of oral submucosal fibrosis.

17. Oropharyngeal stenosis in patient with oral submucous fibrosis: a case report with 8-year follow-up.

18. Panax notoginseng saponins improve oral submucous fibrosis by inhibiting the Wnt/β-catenin signal pathway.

19. Areca nut-induced oral fibrosis - Reassessing the biology of oral submucous fibrosis.

20. Enzyme-linked immunosorbent assay and immunohistochemical analysis of mast cell related biochemicals in oral submucous fibrosis.

21. Estimation of the Salivary Copper Levels in Oral Submucous Fibrosis Condition: An In Vivo Study.

23. Correlation between Vascularity and Advancing Histological Grades of Oral Submucous Fibrosis with a Plausible Role in Malignisation: Systematic review of a persisting matter of conflict.

24. Malignant transformation in oral submucous fibrosis: Tertiary level evidence: An umbrella review.

25. DPSCs regulate epithelial-T cell interactions in oral submucous fibrosis.

26. Serum and salivary interleukin-1β level in oral precancer: An observational study.

27. Evaluation of stromal myofibroblasts in oral submucous fibrosis and its malignant transformation: An immunohistochemical study.

28. Aberrantly downregulated FENDRR by arecoline elevates ROS and myofibroblast activation via mitigating the miR-214/MFN2 axis.

29. Knockdown of Notch Suppresses Epithelial-mesenchymal Transition and Induces Angiogenesis in Oral Submucous Fibrosis by Regulating TGF-β1.

30. Fibroblast activating protein promotes the proliferation, migration, and activation of fibroblasts in oral submucous fibrosis.

31. Expression Profile of Circulating Exosomal microRNAs in Leukoplakia, Oral Submucous Fibrosis, and Combined Lesions of Leukoplakia and Oral Submucous Fibrosis.

32. PDE12 disrupts mitochondrial oxidative phosphorylation and mediates mitochondrial dysfunction to induce oral mucosal epithelial barrier damage in oral submucous fibrosis.

33. Evaluation of possible role of fluoride in pathogenesis of oral submucous fibrosis: A pilot study.

34. Spatial Transcriptomic and Metabolomic Landscapes of Oral Submucous Fibrosis-Derived Oral Squamous Cell Carcinoma and its Tumor Microenvironment.

35. Stromal thrombospondin 1 suppresses angiogenesis in oral submucous fibrosis.

36. Lesion size affects the risk of technical difficulty in gastric endoscopic submucosal dissection.

37. [Oral squamous cell carcinoma in the background of oral submucous fibrosis - a systematic review].

38. Salivary transforming growth factor beta in oral submucous fibrosis: A diagnostic and predictive marker.

39. Mechanism of adipose tissue-derived stromal cell-extracellular vesicles in treating oral submucous fibrosis by blocking the TGF-β1/Smad3 pathway via the miR-760-3p/IGF1R axis.

40. Qualitative Assessment of Collagen and Elastic Fibers in Oral Submucous Fibrosis (OSMF), OSMF with Dysplasia and Oral Squamous Cell Carcinoma Arising from OSMF: A Histochemical Study.

41. Single-cell transcriptomic analysis of gingivo-buccal oral cancer reveals two dominant cellular programs.

42. Novel beagle model of gastric local fibrotic target lesions for the evaluation and training of endoscopic techniques.

43. Expression and correlation of the Pi3k/Akt pathway and VEGF in oral submucous fibrosis.

44. Etiology of Oral Potentially Malignant Disorders and Squamous Cell Carcinoma Based on Cellular Stress Regulation and Matrix Stiffness.

45. Jiawei Danxuan Koukang Alleviates Arecoline Induced Oral Mucosal Lesions: Network Pharmacology and the Combined Ultra-High Performance Liquid Chromatography (UPLC) and Mass Spectrometry (MS).

46. Evaluation of Platelet Parameters in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma in a Background of Oral Submucous Fibrosis.

47. Fibrotic Matrix Induces Mesenchymal Transformation of Epithelial Cells in Oral Submucous Fibrosis.

48. The preliminary exploration of immune microenvironment in oral leukoplakia concomitant with oral submucosal fibrosis: A comparative immunohistochemical study.

49. Comparison of Immunohistochemical Markers in Oral Submucous Fibrosis and Oral Submucous Fibrosis Transformed to Oral Squamous Cell Carcinoma-A Systematic Review and Meta-Analysis.

50. Interleukin-13 contributes to the occurrence of oral submucosal fibrosis.

Catalog

Books, media, physical & digital resources